CLINICAL_TRIALS
research
· 2025-04-15
Clinical Trial Update: Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating neoadjuvant chemotherapy for high-risk upper tract urothelial carcinoma; the study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Changhai Hospital | Conditions: UTUC, NAC | Phase 2 | Status: NOT_YET_RECRUITING